Examkin

Soru

Zorluk: OrtaSchizophrenia and Psychotic Disorders

A 24-year-old man is diagnosed with schizophrenia after a 9-month history of auditory hallucinations, disorganized speech, and persecutory delusions. He has no significant past medical history and his urine toxicology screen is negative. His psychiatrist is developing a comprehensive pharmacological management plan to address his symptoms. The physician considers the various stages of psychopharmacological treatment, from the initial presentation to the potential development of severe refractoriness. Arrange the following therapeutic steps in the correct sequential order for the standard stepwise management of this patient's illness, starting with the initial intervention.

  1. 1Initiation of an oral first-line antipsychotic (e.g., risperidone) as initial monotherapy
  2. 2Switch to a different first-line antipsychotic (e.g., olanzapine) as a second monotherapy trial
  3. 3Initiation of clozapine therapy with absolute neutrophil count (ANC) monitoring
  4. 4Augmentation of clozapine with electroconvulsive therapy (ECT) or an additional psychotropic agent

Cevap

The correct sequence for the pharmacological management of schizophrenia is: initial trial of a first-line antipsychotic, followed by a trial of a different first-line antipsychotic, then initiation of clozapine for treatment resistance, and finally augmentation of clozapine if symptoms persist.
The standard treatment algorithm for schizophrenia involves sequential trials to balance symptom control with medication side effects. Initially, a first-line agent is trialed for 4 to 6 weeks. If this fails, a second first-line agent with a different profile is trialed. Failure of two adequate trials defines treatment-resistant schizophrenia, for which clozapine is the most effective evidence-based treatment. If a patient remains symptomatic despite an adequate clozapine trial, augmentation strategies such as ECT or adding another antipsychotic are indicated.

Adım Adım Çözüm

1
Identify the initial standard of care for a newly diagnosed patient.
Initiation of an oral first-line antipsychotic as initial monotherapy.
First- and second-generation antipsychotics (excluding clozapine) are the standard initial therapies due to their favorable balance of efficacy and side effects.
2
Determine the next appropriate step if the first medication fails.
Switch to a different first-line antipsychotic as a second monotherapy trial.
Before declaring treatment resistance, a patient must fail two adequate trials of different antipsychotic medications.
3
Identify the gold standard treatment for true treatment-resistant schizophrenia.
Initiation of clozapine therapy with ANC monitoring.
Clozapine is specifically indicated for patients who have failed at least two antipsychotic trials, owing to its superior efficacy in refractory cases despite its risk of agranulocytosis.
4
Determine the final intervention for patients who do not fully respond to clozapine.
Augmentation of clozapine with ECT or an additional psychotropic agent.
When clozapine monotherapy is insufficient, augmenting the regimen is the final pharmacological and somatic line of defense.

Anahtar Kavram

Stepwise psychopharmacological management of schizophrenia and the definition of treatment-resistant schizophrenia
Bu soruyu puanla

Konular

Schizophrenia and Psychotic Disorders

Bu konudan daha fazla soru